Oncolytics Biotech Inc T.ONC

New Press Release - Oncolytics Biotech® Announces US$15 Million Bought Deal Offering of Units

Not for distribution to U.S. Newswire Services or Dissemination in the United StatesCALGARY, AB, July 31, 2023 /CNW/ -- Oncolytics Biotech® Inc. ("Oncolytics" or the "Company") (NASDAQ: ONCY) (TSX: ONC) today announced that it has entered into an agreement with Leede Jones Gable Inc. as...read article.

[Lesalpes29]

?? 2.25! OK...

[itntdf]

Each Warrant will entitle the holder thereof to purchase one Common Share at an exercise price of US$2.81 (the "Exercise Price") at any time up to 60 months following the Closing. Friday's closing price in the U.S. on Friday was $2.81.

[Lesalpes29]

Good news anyway, first of many! Have a good week,

[Snowdrift]

It's good news that money will be coming into the coffers.  But doesn't it suggest that they're not being bought out?  If they had a buyout offer, they wouldn't need to raise cash.

[Noteable]

Curiously this bought deal comes on the same day that Adlai Nortye begins trading on the NASDAQ after being underwritten by Cantor Fitzgerald and CSLA/CITIC Securities . CITIC Securities is China's leading brokerage and investment bank https://www.iposcoop.com/ipo/adlai-nortye-ltd/ Cantor Fitzgerald is one of the two lead underwriters for the Adlai Nortye IPO filed with the SEC on

[Noteable]

CLSA Ltd. (formerly known as Credit Lyonnais Securities Asia) is a capital markets and investment group focused on alternative investment, asset management, corporate finance and capital markets, securities and wealth management for corporate and institutional clients. Founded in 1986 by two former journalists, CLSA has its headquarters in Hong Kong and offices or representatives